Significant achievement of the Yuhan anb Boehringer duo in the outpatient prescription market

While the domestic outpatient prescription market has been depressed since the pharmaceutical price cuts in 2012, the top company ranking has met many changes.

Some of the top companies which had led the prescription market – Novartis, Dong-A ST and GSK – encountered large decreases in sales, but Chong Kun Dang and Hanmi Pharm raised themselves in the ranking.

Among the top ranked companies, ...